Warren Urges FTC To Closely Scrutinize Novo Nordisk-Catalent Merger, Block if Illegal Under Antitrust Law
October 10, 2024
October 10, 2024
WASHINGTON, Oct. 10 -- Sen. Elizabeth Warren, D-Massachusetts, issued the following news release:
Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, and block the deal if it is found to be illegal under antitrust law. In the letter, Senator Warren raises concerns that the merger could hurt Ameri . . .
Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, and block the deal if it is found to be illegal under antitrust law. In the letter, Senator Warren raises concerns that the merger could hurt Ameri . . .